# Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

> **NCT04694846** · NA · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 19 (actual)

## Conditions studied

- Lung Non-Small Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Nicotine Replacement
- **DRUG:** Bupropion Hydrochloride Controlled-release
- **DRUG:** Varenicline
- **OTHER:** Tobacco Cessation Counseling
- **OTHER:** Questionnaire Administration
- **OTHER:** Quality of Life Assessment
- **OTHER:** Best Practice

## Key facts

- **NCT ID:** NCT04694846
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-19
- **Primary completion:** 2024-08-16
- **Final completion:** 2024-08-16
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04694846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04694846, "Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04694846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*